NDC 63629-9264

Sodium Sulfacetamide

Sodium Sulfacetamide

Sodium Sulfacetamide is a Topical Liquid in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Sulfacetamide Sodium.

Product ID63629-9264_712e0a2f-d0c7-475e-9552-a562f8585d90
NDC63629-9264
Product TypeHuman Prescription Drug
Proprietary NameSodium Sulfacetamide
Generic NameSodium Sulfacetamide
Dosage FormLiquid
Route of AdministrationTOPICAL
Marketing Start Date2022-01-15
Marketing CategoryUNAPPROVED DRUG OTHER /
Labeler NameBryant Ranch Prepack
Substance NameSULFACETAMIDE SODIUM
Active Ingredient Strength100 mg/g
Pharm ClassesSulfonamide Antibacterial [EPC], Sulfonamides [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63629-9264-1

480 g in 1 BOTTLE (63629-9264-1)
Marketing Start Date2022-04-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Sodium Sulfacetamide" or generic name "Sodium Sulfacetamide"

NDCBrand NameGeneric Name
0168-0484Sodium SulfacetamideSodium Sulfacetamide
16477-410Sodium SulfacetamideSodium Sulfacetamide
42192-129SODIUM SULFACETAMIDESODIUM SULFACETAMIDE
42192-146Sodium SulfacetamideSodium Sulfacetamide
42808-100SODIUM SULFACETAMIDESODIUM SULFACETAMIDE
44523-510Sodium SulfacetamideSodium Sulfacetamide
44523-606SODIUM SULFACETAMIDESODIUM SULFACETAMIDE
44523-613SODIUM SULFACETAMIDESODIUM SULFACETAMIDE
58657-477Sodium SulfacetamideSodium Sulfacetamide
63629-9262Sodium SulfacetamideSodium Sulfacetamide
63629-9263Sodium SulfacetamideSodium Sulfacetamide
63629-9264Sodium SulfacetamideSodium Sulfacetamide
68682-010Sodium sulfacetamideSodium sulfacetamide
69437-410Sodium SulfacetamideSodium Sulfacetamide
71399-0480SODIUM SULFACETAMIDESODIUM SULFACETAMIDE
71399-1599SODIUM SULFACETAMIDESODIUM SULFACETAMIDE
42808-103Exact-Rx Sodium Sulfacetamide Wash 10%SODIUM SULFACETAMIDE
0178-0630OVACESODIUM SULFACETAMIDE
0178-0696OvaceSODIUM SULFACETAMIDE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.